Provided by Tiger Fintech (Singapore) Pte. Ltd.

Booz Allen Hamilton

113.05
-2.0700-1.80%
Post-market: 114.000.9500+0.84%19:46 EDT
Volume:4.38M
Turnover:493.86M
Market Cap:14.04B
PE:15.59
High:120.05
Open:116.99
Low:109.56
Close:115.12
Loading ...

Booz Allen Hamilton Expands Venture Capital Commitment to $300 Million to Boost U.S. Tech Innovation

Reuters
·
21 Jul

Cantor Fitzgerald Keeps Their Buy Rating on Booz Allen (BAH)

TIPRANKS
·
18 Jul

Booz Allen Ventures Invests in Firestorm Labs to Enhance U.S. Defense Capabilities with Advanced 3D-Printed Military Drones

Reuters
·
16 Jul

Corsha announces strategic investment from Booz Allen Ventures

TIPRANKS
·
10 Jul

Booz Allen Ventures Invests in Corsha to Enhance U.S. Cybersecurity Resilience

Reuters
·
10 Jul

Booz Allen Hamilton Price Target Announced at $112.00/Share by Stifel

Dow Jones
·
25 Jun

BUZZ-Stifel initiates coverage on defense stocks

Reuters
·
24 Jun

Booz Allen resumed with a Hold at Stifel

TIPRANKS
·
24 Jun

Booz Allen Hamilton Holding Corporation to Release First Quarter Fiscal 2026 Financial Results

Reuters
·
13 Jun

BRIEF-Booz Allen Wins 2025 Cogswell Award For Security Excellence

Reuters
·
12 Jun

Booz Allen announces strategic investment in ConductorAI

TIPRANKS
·
10 Jun

Booz Allen Hamilton Ventures Invests in ConductorAI to Enhance Government Efficiency Through AI Solutions

Reuters
·
10 Jun

Government Contractors Temper Outlooks as White House Seeks Spending Cuts -- Analysis

Dow Jones
·
05 Jun

Booz Allen Hamilton Appoints Former National Security Advisor Robert C. O'Brien to Board of Directors

Reuters
·
04 Jun

Trump Administration Targets Tech Firms as It Cuts More Contracts -- WSJ

Dow Jones
·
01 Jun

Buy/Sell: Wall Street's Top 10 Stock Calls This Week

The Fly
·
01 Jun

Spotting Winners: NV5 Global (NASDAQ:NVEE) And Government & Technical Consulting Stocks In Q1

StockStory
·
30 May

BofA Maintains Buy Rating on Booz Allen Hamilton (BAH) Stock

Insider Monkey
·
30 May

J.P. Morgan Keeps Their Sell Rating on Booz Allen (BAH)

TIPRANKS
·
30 May

U.S. RESEARCH ROUNDUP-Claritev, Rocket Pharmaceuticals, Salesforce

Reuters
·
29 May